Prospective study of NEOadjuvant Anastrozole and RadioTherapy for hormone-responsive postmenopausal breast cancer (NEO-A-RT)
Phase 2
- Conditions
- early breast cancer
- Registration Number
- JPRN-UMIN000002266
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1)past history of any invasive malignancy within the previous 5 years 2)past history of breast cancer or synchronous bilateral breast cancer 3)past history of radiotherapy for ipsilateral breast 4)Suspicious of allergy for radiotherapy 5)Past use of aromatase inhibitors 6)Suspicious of allergy for aromatase inhibitors 7)Patients who had received or are receiving any steroids, estrogens or selective estrogen receptor modulators 8)Any reason the physician believes that the patient is not appropriate to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method